
Drugs In Context
Get Full AccessDescription
- Drugs in Context a continuous publication, open access, peer-reviewed journal. PubMed indexed.Drugs in Context motivates improvements to clinical practice by publishing original, peer-reviewed articles quickly. In line with the principle of providing context for health care professionals to properly inform and improve disease management in real world medicine, we especially encourage the submission of articles that provide context for trials of drug interventions in order to motivate improvements in disease management by HCPs in the front line of the practice of medicine.For further information:North AmericaDorothy Pennachio, US Editorial Consultantdorothypennachio@yahoo.comTel: +1 201 819 6296UK, Europe and Rest of WorldJulia Savory, Head of Digital Publishing and Submissions Managementjulia@justmedicalmedia.comDDI/mobile: +44 (0)7748 100 680Tel: +44 (0)1242 910 999
-
Headquarters: , , , United States
More -
Phone Number:
-
-
Employees:0
-
Revenue:
-
Legal Name:Drugs In Context
-
Drugs In Context's Social Media
-
Is this data correct?
-
| NAICS Code: 511120 |
Show More
Frequently Asked Questions regarding Drugs In Context
-
What is Drugs In Context's NAICS code?
Drugs In Context's NAICS code is 511120
-
What is Drugs In Context's Industry?
Drugs In Context is in the industry of Publishing
-
Who is Drugs In Context's CEO?
Drugs In Context's CEO is Joel Evans